Unit
Gastroenterology/Hepatology
GASTRO · Dept. I
Low frequency of colorectal dysplasia in patients with long-standing inflammatory bowel disease colitis: detection by fluorescence endoscopy
Ochsenkühn T, Tillack C, Stepp H, Diebold J, Ott S, Baumgartner R, Brand S, Göke B, Sackmann M. Low frequency of colorectal dysplasia in patients with long-standing inflammatory bowel disease colitis: detection by fluorescence endoscopy. Endoscopy 2006; 38:477-82.
May 1, 2006Low frequency of colorectal dysplasia in patients with long-standing inflammatory bowel disease colitis: detection by fluorescence endoscopy
May 1, 2006Endoscopy 2006; 38:477-82
Ochsenkühn T, Tillack C, Stepp H, Diebold J, Ott S J, Baumgartner R, Brand Stephan, Göke B, Sackmann M
Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy
Seiderer J, Zech C, Diebold J, Schoenberg S, Brand S, Tillack C, Göke B, Ochsenkühn T. Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy. Eur J Gastroenterol Hepatol 2006; 18:553-5.
May 1, 2006Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy
May 1, 2006Eur J Gastroenterol Hepatol 2006; 18:553-5
Seiderer Julia, Zech Christoph J, Diebold Joachim, Schoenberg Stefan O, Brand Stephan, Tillack Cornelia, Göke Burkhard, Ochsenkühn Thomas
Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells
Zitzmann K, Brand S, Baehs S, Göke B, Meinecke J, Spöttl G, Meyer H, Auernhammer C. Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells. Biochem Biophys Res Commun 2006; 344:1334-41.
Apr 24, 2006Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells
Apr 24, 2006Biochem Biophys Res Commun 2006; 344:1334-41
Zitzmann Kathrin, Brand Stephan, Baehs Sebastian, Göke Burkhard, Meinecke Jennifer, Spöttl Gerald, Meyer Heinrich, Auernhammer Christoph J
IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration
Brand S, Auernhammer C, Göke B, Ochsenkühn T, Seiderer J, Herrmann K, Leclair S, Popp A, Jagla W, Marquardt A, Diepolder H, Otte J, Eichhorst S, Zitzmann K, Olszak T, Beigel F, Dambacher J. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 2006; 290:G827-38.
Apr 1, 2006IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration
Apr 1, 2006Am J Physiol Gastrointest Liver Physiol 2006; 290:G827-38
Brand Stephan, Auernhammer Christoph J, Göke Burkhard, Ochsenkühn Thomas, Seiderer Julia, Herrmann Karin, Leclair Stéphane, Popp Andreas, Jagla Wolfgang, Marquardt Andreas, Diepolder Helmut, Otte Jan-Michel, Eichhorst Sören T, Zitzmann Kathrin, Olszak Torsten, Beigel Florian, Dambacher Julia
Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin
Berg T, Alshuth U, Martus P, Spengler U, Klinker H, Kallinowski B, Schmidt W, Pape G, Rasenack J, Goeser T, Buggisch P, Gerlach T, Heintges T, Sarrazin C, Nasser S, von Wagner M, Zeuzem S. Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin. Gastroenterology 2006; 130:1086-97.
Apr 1, 2006Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin
Apr 1, 2006Gastroenterology 2006; 130:1086-97
Berg Thomas, Alshuth Ulrich, Martus Peter, Spengler Ulrich, Klinker Hartwig, Kallinowski Birgit, Schmidt Wolfgang E, Pape Gerd R, Rasenack Jens, Goeser Tobias, Buggisch Peter, Gerlach Tilman, Heintges Tobias, Sarrazin Christoph, Nasser Samer, von Wagner Michael, Zeuzem Stefan
GRK2 makes trouble: a no-NO in portal hypertension
Semela D, Langer D, Shah V. GRK2 makes trouble: a no-NO in portal hypertension. Gastroenterology 2006; 130:1001-3; discussion 1003.
Mar 1, 2006GRK2 makes trouble: a no-NO in portal hypertension
Mar 1, 2006Gastroenterology 2006; 130:1001-3; discussion 1003
Semela David, Langer Daniel A, Shah Vijay
Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells
Brand S, Olszak T, Beigel F, Diebold J, Otte J, Eichhorst S, Göke B, Dambacher J. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. J Cell Biochem 2006; 97:709-23.
Mar 1, 2006Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells
Mar 1, 2006J Cell Biochem 2006; 97:709-23
Brand Stephan, Olszak Torsten, Beigel Florian, Diebold Joachim, Otte Jan-Michel, Eichhorst Soeren T, Göke Burkhard, Dambacher Julia
Eight novel CARD15 variants detected by DNA sequence analysis of the CARD15 gene in 111 patients with inflammatory bowel disease
Schnitzler F, Ochsenkühn T, Göke B, Tillack C, Seiderer J, Hofbauer K, Pfennig S, Staudinger T, Brand S, Lohse P. Eight novel CARD15 variants detected by DNA sequence analysis of the CARD15 gene in 111 patients with inflammatory bowel disease. Immunogenetics 2006; 58:99-106.
Feb 17, 2006Eight novel CARD15 variants detected by DNA sequence analysis of the CARD15 gene in 111 patients with inflammatory bowel disease
Feb 17, 2006Immunogenetics 2006; 58:99-106
Schnitzler Fabian, Ochsenkühn Thomas, Göke Burkhard, Tillack Cornelia, Seiderer Julia, Hofbauer Katrin, Pfennig Simone, Staudinger Tanja, Brand Stephan, Lohse Peter
Klinische Untersuchung: Macht der Ultraschall die klinische untersuchung des Abdomens überflüssig?
Meyenberger C. Klinische Untersuchung: Macht der Ultraschall die klinische untersuchung des Abdomens überflüssig?. Therapeutische Umschau 2006; 63:475-478.
Jan 1, 2006Klinische Untersuchung: Macht der Ultraschall die klinische untersuchung des Abdomens überflüssig?
Jan 1, 2006Therapeutische Umschau 2006; 63:475-478
Meyenberger Christa
Proktologische Diagnostik
Meyenberger C, Lange J, Mölle B, Girona J. Proktologische Diagnostik. In: Chirurgische Proktologie. Heidelberg: Springer, 2006.
Jan 1, 2006Proktologische Diagnostik
Jan 1, 2006Springer
Meyenberger Christa, Lange Jochen, Mölle B, Girona J
Eile mit Weile
Frei R, Moll C, Kurath J, Krause M. Eile mit Weile. Therapeutische Umschau 2006; 63:749-752.
Jan 1, 2006Eile mit Weile
Jan 1, 2006Therapeutische Umschau 2006; 63:749-752
Frei Remus, Moll C, Kurath J, Krause M
Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype
Brand S, Ochsenkühn T, Göke B, Konrad A, Tillack C, Seiderer J, Pfennig S, Staudinger T, Schnitzler F, Dambacher J, Hofbauer K, Lohse P. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype. Am J Gastroenterol 2006; 101:99-106.
Jan 1, 2006Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype
Jan 1, 2006Am J Gastroenterol 2006; 101:99-106
Brand Stephan, Ochsenkühn Thomas, Göke Burkhard, Konrad Astrid, Tillack Cornelia, Seiderer Julia, Pfennig Simone, Staudinger Tanja, Schnitzler Fabian, Dambacher Julia, Hofbauer Katrin, Lohse Peter
Hypertonus, tachycardia, and sweating: pheochromocytoma – or not?
Sulz M. Hypertonus, tachycardia, and sweating: pheochromocytoma – or not?. Schweiz Med Forum 2005; 49:1234-1237.
Dec 11, 2005Hypertonus, tachycardia, and sweating: pheochromocytoma – or not?
Dec 11, 2005Schweiz Med Forum 2005; 49:1234-1237
Sulz Michael
CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation
Brand S, Dambacher J, Beigel F, Olszak T, Diebold J, Otte J, Göke B, Eichhorst S. CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res 2005; 310:117-30.
Oct 15, 2005CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation
Oct 15, 2005Exp Cell Res 2005; 310:117-30
Brand Stephan, Dambacher Julia, Beigel Florian, Olszak Torsten, Diebold Joachim, Otte Jan-Michel, Göke Burkhard, Eichhorst Sören T
Infliximab zur Therapie chronisch entzündlicher Darmerkrankungen
Seiderer J, Schnitzler F, Brand S, Tillack C, Göke B, Ochsenkühn T. Infliximab zur Therapie chronisch entzündlicher Darmerkrankungen. Dtsch Arztebl 2005; 102:828-833.
Oct 4, 2005Infliximab zur Therapie chronisch entzündlicher Darmerkrankungen
Oct 4, 2005Dtsch Arztebl 2005; 102:828-833
Seiderer J, Schnitzler F, Brand Stephan, Tillack C, Göke B, Ochsenkühn T
The Novel Lambda-Interferons IL-28A and IL-29 Mediate Proinflammatory, Antiproliferative, and Antiviral Signals in Intestinal Epithelial Cells
Brand S, Auernhammer C, Adler B, Diepolder H, Göke B, Otte J, Eichhorst S, Zitzmann K, Olszak T, Beigel F, Dambacher J. The Novel Lambda-Interferons IL-28A and IL-29 Mediate Proinflammatory, Antiproliferative, and Antiviral Signals in Intestinal Epithelial Cells. Gastroenterology 2005; 129:371-371.
Oct 4, 2005The Novel Lambda-Interferons IL-28A and IL-29 Mediate Proinflammatory, Antiproliferative, and Antiviral Signals in Intestinal Epithelial Cells
Oct 4, 2005Gastroenterology 2005; 129:371-371
Brand Stephan, Auernhammer Christoph J, Adler Barbara, Diepolder Helmut, Göke B, Otte J-M, Eichhorst Soeren T, Zitzmann K, Olszak Torsten, Beigel F, Dambacher J
Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins
Gerlach T, Pape G, Zachoval R, Vogler A, Zahn R, Witter K, Scholz S, Heeg M, Schirren C, Schraut W, Jung M, Grüner N, Ulsenheimer A, Diepolder H. Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins. Journal of virology 2005; 79:12425-33.
Oct 1, 2005Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins
Oct 1, 2005Journal of virology 2005; 79:12425-33
Gerlach Tilman, Pape G R, Zachoval R, Vogler A, Zahn R, Witter K, Scholz S, Heeg M, Schirren C-A, Schraut W, Jung M-C, Grüner N H, Ulsenheimer A, Diepolder H M
The influence of postural changes on gastroesophageal reflux and barrier pressure in nonfasting individuals
Jeske H, Borovicka J, von Goedecke A, Meyenberger C, Heidegger T, Benzer A. The influence of postural changes on gastroesophageal reflux and barrier pressure in nonfasting individuals. Anesthesia and analgesia 2005; 101:597-600, table of contents.
Aug 1, 2005The influence of postural changes on gastroesophageal reflux and barrier pressure in nonfasting individuals
Aug 1, 2005Anesthesia and analgesia 2005; 101:597-600, table of contents
Jeske Hans-Christian, Borovicka Jan, von Goedecke Achim, Meyenberger Christa, Heidegger Thomas, Benzer Arnulf
Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C
von Wagner M, Herrmann E, Häussinger D, Bernsmeier C, Bergk A, Heintges T, Rasenack J, Hinrichsen H, Berg T, Huber M, Zeuzem S. Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C. Gastroenterology 2005; 129:522-7.
Aug 1, 2005Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C
Aug 1, 2005Gastroenterology 2005; 129:522-7
von Wagner Michael, Herrmann Eva, Häussinger Dieter, Bernsmeier Christine, Bergk Alexandra, Heintges Tobias, Rasenack Jens, Hinrichsen Holger, Berg Thomas, Huber Miriam, Zeuzem Stefan
IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression
Brand S, Göke B, Auernhammer C, Adler B, Diepolder H, Diebold J, Otte J, Eichhorst S, Zitzmann K, Olszak T, Beigel F, Dambacher J. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol 2005; 289:G960-8.
Jul 28, 2005IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression
Jul 28, 2005Am J Physiol Gastrointest Liver Physiol 2005; 289:G960-8
Brand Stephan, Göke Burkhard, Auernhammer Christoph J, Adler Barbara, Diepolder Helmut, Diebold Joachim, Otte Jan-Michel, Eichhorst Sören T, Zitzmann Kathrin, Olszak Torsten, Beigel Florian, Dambacher Julia